Patent Number: 7,709,220

Title: Methods of monitoring treatment of BAFF-R related disease

Abstract: Disclosed are nucleic acids encoding BAFF-R polypeptides, as well as antibodies to BAFF-R polypeptides and pharmaceutical compositions including the same. Methods of treating tumorigenic and autoimmune conditions using the nucleic acids, polypeptides, antibodies and pharmaceutical compositions of this invention are also provided.

Inventors: Ambrose; Christine M. (Reading, MA), Thompson; Jeffrey S. (Stoneham, MA)

Assignee: Biogen Idec MA Inc.

International Classification: G01N 33/53 (20060101); C07K 14/705 (20060101); G01N 33/50 (20060101)

Expiration Date: 5/04/12018